These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26240979)

  • 21. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.
    Truninger K; Menigatti M; Luz J; Russell A; Haider R; Gebbers JO; Bannwart F; Yurtsever H; Neuweiler J; Riehle HM; Cattaruzza MS; Heinimann K; Schär P; Jiricny J; Marra G
    Gastroenterology; 2005 May; 128(5):1160-71. PubMed ID: 15887099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human PMS2 gene family: origin, molecular evolution, and biological implications.
    Shpakovskii DG; Shematorova EK; Shpakovskii GV
    Dokl Biochem Biophys; 2006; 408():175-9. PubMed ID: 16913423
    [No Abstract]   [Full Text] [Related]  

  • 23. An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers.
    Goel A; Nagasaka T; Hamelin R; Boland CR
    PLoS One; 2010 Feb; 5(2):e9393. PubMed ID: 20195377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
    Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
    Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
    Drost M; Koppejan H; de Wind N
    Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of colorectal adenocarcinomas at single-institution with respect to microsatellite instability.
    Ozkara S; Sari B; Yesil A; Aktekin A; Sezikli M; Cetinkaya Z; Aker F
    Chirurgia (Bucur); 2013; 108(4):473-7. PubMed ID: 23958088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
    Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
    Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts.
    Sjursen W; Bjørnevoll I; Engebretsen LF; Fjelland K; Halvorsen T; Myrvold HE
    Fam Cancer; 2009; 8(3):179-86. PubMed ID: 19039682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
    Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
    Qi Y; Schoene NW; Lartey FM; Cheng WH
    J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal Cancer due to Constitutional Mismatch Repair Deficiency Mimicking Neurofibromatosis I.
    Urganci N; Genc DB; Kose G; Onal Z; Vidin OO
    Pediatrics; 2015 Oct; 136(4):e1047-50. PubMed ID: 26391938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing mismatch repair to model sporadic cancers.
    Fishel R; Groden J
    Nat Methods; 2008 Mar; 5(3):225-6. PubMed ID: 18309309
    [No Abstract]   [Full Text] [Related]  

  • 35. Pleomorphic rhabdomyosarcoma in a patient with hereditary nonpolyposis colorectal cancer.
    Cranmer LD; Chen CC; Morgan S; Martino G; Ray J
    J Clin Oncol; 2013 Mar; 31(7):e108-10. PubMed ID: 23319697
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation and management of Lynch syndrome.
    Boland CR
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
    [No Abstract]   [Full Text] [Related]  

  • 37. The gastrointestinal manifestation of constitutional mismatch repair deficiency syndrome: from a single adenoma to polyposis-like phenotype and early onset cancer.
    Levi Z; Kariv R; Barnes-Kedar I; Goldberg Y; Half E; Morgentern S; Eli B; Baris HN; Vilkin A; Belfer RG; Niv Y; Elhasid R; Dvir R; Abu-Freha N; Cohen S
    Clin Genet; 2015 Nov; 88(5):474-8. PubMed ID: 25307252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
    Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
    Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticipating phenotypic differences from genetic mutations.
    You YN
    Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
    Auclair J; Leroux D; Desseigne F; Lasset C; Saurin JC; Joly MO; Pinson S; Xu XL; Montmain G; Ruano E; Navarro C; Puisieux A; Wang Q
    Hum Mutat; 2007 Nov; 28(11):1084-90. PubMed ID: 17557300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.